Barclays Reaffirms Hold with $136 Target as Zoetis Q4 Revenue Rises 3%
Barclays reaffirmed its Hold rating on Zoetis with a $136 price target after Q4 revenue rose 3% to $2.4 billion and net income reached $603 million. For full year 2025, revenue climbed 2% to $9.5 billion and net income increased 8% to $2.7 billion.
1. Barclays Rating
Barclays maintained its Hold rating on Zoetis on February 18, setting a $136 per share price objective. The reaffirmation follows the release of Zoetis’s fiscal Q4 and full year 2025 results.
2. Q4 2025 Financial Results
In fiscal Q4 2025, Zoetis reported $2.4 billion in revenue, up 3% year-over-year and 4% on an organic basis. Net income for the quarter reached $603 million, or $1.37 per diluted share, reflecting reported increases of 4% and per-share gains of 6%.
3. Full Year 2025 Performance
For the full year 2025, Zoetis generated $9.5 billion in revenue, marking a 2% increase overall and 6% organic growth. Net income for the year climbed 8% to $2.7 billion, or $6.02 per diluted share.